BTK inhibitors
5 abstracts
Abstract
Very long-term follow-up of rituximab maintenance in young patients with mantle cell lymphoma included in the LYMA trial, a LYSA study.Org: Institut Curie, Saint Cloud, France, Hemato-oncology, IUCT-Oncopole Toulouse, Department of Hemagology, Centre François Magendie,
Abstract
Real-world outcomes of brexucabtagene autoleucel (brexu-cel) for relapsed or refractory (R/R) mantle cell lymphoma (MCL): A CIBMTR subgroup analysis by prior treatment.Org: City of Hope National Medical Center, Center for International Blood and Marrow Transplant Research, University of North Carolina School of Medicine, Moffitt Cancer Center, Stanford University Hospital,
Abstract
Analysis of racial disparities accounting for treatment received in chronic lymphocytic leukemia: A real-world cohort analysis.Org: Medical Affairs, AstraZeneca Pharmaceuticals, Global Medical Affairs, AstraZeneca Pharmaceuticals, Mount Sinai Comprehensive Cancer Center,
Abstract
Efficacy of COVID vaccinations in patients with chronic lymphocytic leukemia.Org: The Ohio State University - James Cancer Hospital, UT Southwestern Medical Center, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH, Ohio State University Comprehensive Canvcer Hospital,
Abstract
Skin adverse events of anti-cancer treatments: An examination of drug-AE associations.Org: La Roche-Posay International, Levallois-Perret, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, Memorial Sloan Kettering Cancer Center,